These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

275 related articles for article (PubMed ID: 28864616)

  • 1. CXCR4 Ligands: The Next Big Hit?
    Walenkamp AME; Lapa C; Herrmann K; Wester HJ
    J Nucl Med; 2017 Sep; 58(Suppl 2):77S-82S. PubMed ID: 28864616
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A review on CXCR4/CXCL12 axis in oncology: no place to hide.
    Domanska UM; Kruizinga RC; Nagengast WB; Timmer-Bosscha H; Huls G; de Vries EG; Walenkamp AM
    Eur J Cancer; 2013 Jan; 49(1):219-30. PubMed ID: 22683307
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular Pathways: Targeting the CXCR4-CXCL12 Axis--Untapped Potential in the Tumor Microenvironment.
    Scala S
    Clin Cancer Res; 2015 Oct; 21(19):4278-85. PubMed ID: 26199389
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CXCL12-CXCR4 contributes to the implication of bone marrow in cancer metastasis.
    Shi J; Wei Y; Xia J; Wang S; Wu J; Chen F; Huang G; Chen J
    Future Oncol; 2014 Apr; 10(5):749-59. PubMed ID: 24799056
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CXCL12/CXCR4 axis in the microenvironment of solid tumors: A critical mediator of metastasis.
    Mortezaee K
    Life Sci; 2020 May; 249():117534. PubMed ID: 32156548
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chemokine receptor - Directed imaging and therapy.
    Buck AK; Stolzenburg A; Hänscheid H; Schirbel A; Lückerath K; Schottelius M; Wester HJ; Lapa C
    Methods; 2017 Nov; 130():63-71. PubMed ID: 28916148
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The CXCL12 (SDF-1)/CXCR4 chemokine axis: Oncogenic properties, molecular targeting, and synthetic and natural product CXCR4 inhibitors for cancer therapy.
    Zhou Y; Cao HB; Li WJ; Zhao L
    Chin J Nat Med; 2018 Nov; 16(11):801-810. PubMed ID: 30502762
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The role of CXCL12 in tumor microenvironment.
    Meng W; Xue S; Chen Y
    Gene; 2018 Jan; 641():105-110. PubMed ID: 29017963
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CXCR4-directed theranostics in oncology and inflammation.
    Kircher M; Herhaus P; Schottelius M; Buck AK; Werner RA; Wester HJ; Keller U; Lapa C
    Ann Nucl Med; 2018 Oct; 32(8):503-511. PubMed ID: 30105558
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The axis of evil in the fight against cancer.
    Petrushev B; Tomuleasa C; Suşman S; Sorişău O; Aldea M; Kacsó G; Buigă R; Irimie A
    Rom J Intern Med; 2011; 49(4):319-25. PubMed ID: 22568277
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chemokine receptor CXCR4: role in gastrointestinal cancer.
    Lombardi L; Tavano F; Morelli F; Latiano TP; Di Sebastiano P; Maiello E
    Crit Rev Oncol Hematol; 2013 Dec; 88(3):696-705. PubMed ID: 24120239
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CXCL12/CXCR4: a symbiotic bridge linking cancer cells and their stromal neighbors in oncogenic communication networks.
    Guo F; Wang Y; Liu J; Mok SC; Xue F; Zhang W
    Oncogene; 2016 Feb; 35(7):816-26. PubMed ID: 25961926
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of CXCL12/CXCR4 signaling axis in pancreatic cancer.
    Wu PF; Lu ZP; Cai BB; Tian L; Zou C; Jiang KR; Miao Y
    Chin Med J (Engl); 2013; 126(17):3371-4. PubMed ID: 24033967
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The CXCL12-CXCR4 Signaling Axis Plays a Key Role in Cancer Metastasis and is a Potential Target for Developing Novel Therapeutics against Metastatic Cancer.
    Yang P; Hu Y; Zhou Q
    Curr Med Chem; 2020; 27(33):5543-5561. PubMed ID: 31724498
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CXCL14 antagonizes the CXCL12-CXCR4 signaling axis.
    Hara T; Tanegashima K
    Biomol Concepts; 2014 May; 5(2):167-73. PubMed ID: 25372750
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of CXCL12/CXCR4 axis as a potential targeted therapy of advanced gastric carcinoma.
    Xue LJ; Mao XB; Ren LL; Chu XY
    Cancer Med; 2017 Jun; 6(6):1424-1436. PubMed ID: 28544785
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Trafficking of normal stem cells and metastasis of cancer stem cells involve similar mechanisms: pivotal role of the SDF-1-CXCR4 axis.
    Kucia M; Reca R; Miekus K; Wanzeck J; Wojakowski W; Janowska-Wieczorek A; Ratajczak J; Ratajczak MZ
    Stem Cells; 2005 Aug; 23(7):879-94. PubMed ID: 15888687
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The pivotal role of CXCL12 (SDF-1)/CXCR4 axis in bone metastasis.
    Wang J; Loberg R; Taichman RS
    Cancer Metastasis Rev; 2006 Dec; 25(4):573-87. PubMed ID: 17165132
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The CXCR4/CXCL12 axis in cutaneous malignancies with an emphasis on melanoma.
    Mitchell B; Mahalingam M
    Histol Histopathol; 2014 Dec; 29(12):1539-46. PubMed ID: 24879309
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The CXCL12/CXCR4/ACKR3 Axis in the Tumor Microenvironment: Signaling, Crosstalk, and Therapeutic Targeting.
    Smit MJ; Schlecht-Louf G; Neves M; van den Bor J; Penela P; Siderius M; Bachelerie F; Mayor F
    Annu Rev Pharmacol Toxicol; 2021 Jan; 61():541-563. PubMed ID: 32956018
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.